Delivery Order SPE2DR25D2014-SPE2DR26FA3F1
- Not listed
- The Defense Logistics Agency awarded a $15,982.03 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors under a firm fixed-price contract. The award, issued on January 22, 2026, with an ultimate completion date of January 23, 2026, represents a non-set-aside competitive procurement. This delivery order is a child contract executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $71,037.17 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors, with a completion date of January 12, 2026. This is a firm fixed-price delivery order with no set-aside designation, awarded on a competitive basis. The contract is a child award under AmerisourceBergen's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued...
- The Defense Logistics Agency awarded a $16,550.52 delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 8, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price contract is scheduled for completion by January 9, 2026, and will be performed at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, indicating the award was made through full...
- The Defense Logistics Agency awarded a $30,283.68 delivery order to AmerSourceBergen Drug Corp (a subsidiary of parent company Cencora, Inc.) on January 22, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of January 23, 2026. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a task...
- The Defense Logistics Agency awarded a delivery order valued at $35,243.16 to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 16, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 20, 2026, and performance to be fulfilled from the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under Amerisourcebergen's existing Indefinite...
- The Defense Logistics Agency awarded a $9,735.80 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract is firm fixed price with no set-aside designation and is scheduled for completion by August 25, 2025. AmerisourceBergen will perform work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $34,089.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 9, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injector medication. The contract, with an ultimate completion date of January 12, 2026, represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $38,919.56 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with a firm fixed price structure and ultimate completion date of November 25, 2025. This competitively awarded, non-set-aside contract was executed on November 24, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $22,247.52 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector medication on January 15, 2026, with completion scheduled for January 16, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a $6,497.25 delivery order by the Defense Logistics Agency on January 21, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract is non-competitive and structured as a firm fixed-price delivery order with an ultimate completion date of January 22, 2026. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is executed under Amerisourcebergen's...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA3F1Delivery Order
The Defense Logistics Agency awarded a $9,747.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 22, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The order, with an ultimate completion date of January 23, 2026, was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under Cencora, Inc.'s existing Indefinite Delivery Contract with DLA Troop Support Medical, a single-award vehicle valued up to $999,999,999 through December 2031 that provides comprehensive pharmaceutical and medical supply support for military healthcare programs globally. Repatha is a cholesterol-lowering injectable medication used in cardiovascular disease management. AmerisourceBergen, as a major pharmaceutical distributor and healthcare solutions provider, has demonstrated significant capacity to fulfill federal medical procurement requirements across multiple therapeutic domains through its extensive portfolio of federal contracts with the Defense Logistics Agency and Department of Veterans Affairs. The contractor's ability to compete successfully in open competitions and manage delivery orders ranging from modest to substantial values underscores its critical role in supporting military and veteran healthcare systems' pharmaceutical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 1/21/26 |